ANVISA's POV on "triangulation points" [Regulatives / Guidelines]

posted by MarceloCosta – Brazil, 2015-04-06 23:52 (4090 d 05:52 ago) – Posting: # 14667
Views: 14,275

Hello Everybody,

In my point of view there is no doubt about this discussion.

1 - zero is zero.
2 - missing must be interpolated.
3 - No exclusion for outliers.

something different of this is a bad interpretation.

Must be considered in ours SOP's.

Respect all rules. All SOP's. Less manipulation.

For a better Clinical and Analytical pratices.


I know zero point in the middle of the curve is a problem, but what is the cause?
who will decide what to do in each case? I think the Agency will.

Pk Analists and Statisticians must justify your decisions.

Report the real data!!!

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
165 visitors (0 registered, 165 guests [including 22 identified bots]).
Forum time: 05:44 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5